Search

Author/Creator Walsh, Jennifer S

1. Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment. Issue 1 (28th February 2023)

Authors:
Kamenicky, Peter; Briot, Karine; Brandi, Maria Luisa; Cohen-Solal, Martine; Crowley, Rachel K; Keen, Richard; Kolta, Sami; Lachmann, Robin H; Lecoq, Anne-Lise; Ralston, Stuart H; Walsh, Jennifer S; Rylands, Angela J; Williams, Angela; Sun, Wei; Nixon, Annabel; Nixon, Mark; Javaid, Muhammad K
Journal:
RMD open
Issue:
Volume 9:Issue 1(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Long‐Term Selenium‐Yeast Supplementation Does Not Affect Bone Turnover Markers: A Randomized Placebo‐Controlled Trial. (29th September 2022)

Authors:
Perri, Giorgia; Hill, Tom R; Mathers, John C; Walsh, Jennifer S; Gossiel, Fatma; Winther, Kristian; Frölich, Jacob; Folkestad, Lars; Cold, Søren; Eastell, Richard
Journal:
Journal of bone and mineral research
Issue:
Volume 37:Number 11(2022)
Page Start:
2165
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗